Pyxis Oncology PYXS
NASDAQ PYXS
$1.76 -0.08 (-4.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) EBITDA Margin (2024 - 2025)

Updated

Pyxis Oncology's EBITDA Margin came in at -139.50% for Q4 2025.

Analysis

Pyxis Oncology (PYXS) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Pyxis Oncology's EBITDA Margin was -576.63%, down 41.03 percentage points from FY2024.

  • Going back by year, EBITDA Margin was -535.60% in FY2024.
  • The Q4 2025 figure represents the highest quarterly EBITDA Margin since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 35.95%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 49.01%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.11%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -124.26%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 39.16%
10 Pyxis Oncology 112.79 Mn -152.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -139.50%
Jun 30, 2025 -681.38%
Mar 31, 2024 -27.80%
API Access

Pyxis Oncology EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PYXS&period=max&api_key=YOUR_API_KEY